Quinolines as chemotherapeutic agents for leishmaniasis

Kristie A. Reynolds, Wendy A. Loughlin, David J. Young

Research output: Contribution to journalReview article

10 Downloads (Pure)

Abstract

The development of leishmanicidal quinolines and their in vitro (promastigote and amastigote) and, where applicable, in vivo activities are reviewed. This survey provides a direct comparison of bioactivity across different species (e.g. L. donovani, L. amazonensis, L. chagasi, L infantum), and in different animal models (e.g. L. donovani Balb/c mice and L. donovani infected hamsters). The progress of selected quinolines through pre-clinical development and phase I/II trials, and the lead quinoline drugs sitamaquinine and Imiquimod, are discussed in conjunction with delivery systems and combination therapies.

Original languageEnglish
Pages (from-to)730-743
Number of pages14
JournalMini-Reviews in Medicinal Chemistry
Volume13
Issue number5
DOIs
Publication statusPublished - 21 May 2013
Externally publishedYes

Fingerprint Dive into the research topics of 'Quinolines as chemotherapeutic agents for leishmaniasis'. Together they form a unique fingerprint.

Cite this